发明名称 COMPOUNDS WITH CONDENSED 1,3-DIHYDROIMIDAZOLE CYCLE
摘要 FIELD: chemistry. ^ SUBSTANCE: invention relates to producing the novel compounds with dipeptidyl peptidase IV (DPP-IV) inhibiting activity and particularly, it relates to the compounds with the condensed 1,3-dihydroimidazole cycle. The invention relates to the compounds represented by the common formula (II), or their pharmaceutically acceptable salts, where, Z3a means nitrogen atom or the group with formula -CR2a=; X3a means oxygen atom or sulfur atom; T1a means piperazine-1-yl group, 3-amino-piperidine-1-yl group, 3-methylamino-piperidine-1-yl group; X1a means oxygen atom hydrogen, C2-6-alkenyl group, C2-6-alkynyl group or benzyl group; each of R1a and R2a independently means hydrogen atom, halogenatom, C1-6-alkyl group, cyanogroup or group, represented with formula-A0a-A1a; A0a means oxygen atom, sulfur atom or group, represented with formula-NA2a-; Ala means hydrogen atom, C1-6-alkyl group, C1-6-alkenyl group, C2-6-alkynyl group, phenyl group, cyanophenyl group, carbamoylphenyl group, benzyl group; A2a means hydrogen atom or C1-6-alkyl group; X2a means hydrogen atom, C2-6-alkenyl group, C2-6-alkynyl group, 1H-piridine-2-onyl group, 1-methyl-1H-piridine-2-onyl group, C1-6-alkyl group, which can have a group, selected from the substitutes group specified below B, phenyl group, which can have a group, selected from the substitutes group specified below B, 5- or 6-membered heteroarylgroup, containing one or two nitrogen atoms, oxygen or sulfur, which can have a group, selected from the substitutes group specified below B, phenylC1-6-alkyl group, which can have a group, selected from the substitutes group specified below B: substitutes group B is group, including chlorine atom, bromine atom; cyanogroup, C1-b-alkyl group, C2-b-alkenyl group, C2-6-alkynyl group, C3-8-cycloalkyl group, C1-6alcoxigroup, carbamoyl groupcarboxyl group and C1-6-alcoxicarbonyl group. ^ EFFECT: research and revealing compounds with DPP-IV inhibiting activity, useful as pharmaceutical agents which can be used as therapeutic and preventing medicines in such diseases as diabetes, obesity and hyperlipidemia. ^ 12 cl, 84 ex, 2 tbl
申请公布号 RU2328498(C9) 申请公布日期 2008.12.10
申请号 RU20050120780 申请日期 2003.12.02
申请人 EHJSAJ AR EHND DI MENEDZHMENT KO., LTD. 发明人 KIRA KAZUNOBU;KLARK RICHARD;JOSIKAVA SEJDZI;UEKHARA TAJSUKE
分类号 C07D487/04;A61K31/522;A61P1/00;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P5/00;A61P9/00;A61P15/08;A61P19/10;A61P25/00;A61P29/00;A61P31/18;A61P35/00;A61P37/02;A61P37/08;A61P43/00;C07D471/04;C07D473/16;C07D473/18;C07D473/24;C07D473/32;C07D473/40 主分类号 C07D487/04
代理机构 代理人
主权项
地址